AU Patent

AU2016205003B2 — Phosphorous derivatives as kinase inhibitors

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2018-02-22 · 8y expired

What this patent protects

H:iXD nnvoye RPortbl\DC SXD\065016_.doc-I IM4/2OI3 The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

USPTO Abstract

H:iXD nnvoye RPortbl\DC SXD\065016_.doc-I IM4/2OI3 The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016205003B2
Jurisdiction
AU
Classification
—
Expires
2018-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.